Anavex Life Sciences Corp (AVXL)

[UnderVerse]

PHASE 2/3 for 2-73:

Per Anavex IR:
Thank you for your email and continued support of Anavex Life Sciences Corp. (Nasdaq: AVXL).



Anavex is funded for clinical outcome. The larger Phase 2/3 Alzheimer’s trial will start after Phase 2a PK/PD data is available. The reason for this is that this data is relevant for key parameters of subsequent trials like the larger Phase 2/3 Alzheimer’s trial.



Please do not hesitate to contact our office if we can be of further assistance.



On behalf of Anavex Life Sciences Corp.,



Investor Relations

Toll Free (North America): 1 [phone]

Outside North America: [phone]

Fax: [phone]

[e-mail]